Indian equity markets enter Monday, October 26, after ending the previous trading week on a weaker note. On Friday, October 23, the Nifty 50 declined 87.65 points, or 0.39%, to close at 22,600.00, while the BSE Sensex fell 125.56 points, or 0.17%, to settle at 73,123.83. The decline extended the benchmarks’ losing streak to four consecutive trading sessions.
The September-quarter earnings season remains a major focus for investors, with several large companies reporting financial results after Friday’s market session and over the weekend. Infosys, Kotak Mahindra Bank, Coforge, Dr. Reddy’s Laboratories, IndusInd Bank and Bank of India are among the companies attracting attention following their latest earnings announcements. Investors will also monitor global market developments, crude oil prices and institutional activity.
FII/DII Activity – October 23, 2026
| Investor Category | Net Activity |
|---|---|
| Foreign Institutional Investors (FII/FPI) | +₹887.65 crore |
| Domestic Institutional Investors (DII) | +₹3,235.36 crore |
Both foreign and domestic institutional investors were net buyers in the cash market on Friday. Combined net institutional purchases stood at ₹4,123.01 crore. Despite these inflows, the benchmark indices closed lower, highlighting the importance of broader selling activity and company-specific market movements. Investors will monitor whether institutional buying continues during the new trading week.
Stocks to Watch Today – Quick Summary
| Stock | Why It Is in Focus |
|---|---|
| Infosys | Q2 profit rises 6.2%; FY27 guidance maintained |
| Kotak Mahindra Bank | Standalone profit increases 29.5% |
| Dr. Reddy’s Laboratories | Quarterly profit declines 36% |
| IndusInd Bank | Returns to quarterly profitability |
| Bank of India | Standalone profit rises 25.4% |
| Coforge | Profit and revenue increase more than 50% |
| Torrent Pharmaceuticals | Revenue rises while profit declines |
| Netweb Technologies | Strong quarterly revenue and profit growth |
| Apollo Micro Systems | Higher defence electronics revenue and profit |
| Paytm (One 97 Communications) | Q2 results scheduled for October 26 |
Infosys
Infosys reported a 6.2% year-on-year increase in consolidated net profit to ₹7,823 crore for the September quarter, compared with ₹7,364 crore in the corresponding period last year. Revenue increased 10.7% to ₹49,244 crore, while operating profit rose 10.4% to ₹10,330 crore. The operating margin stood at 21%.
Also Read: Sensex, Nifty Today, October 26: Markets Rebound From Early Losses as Pharma and Banking Stocks Gain
The company maintained its FY27 constant-currency revenue growth guidance of 1–2% and operating margin guidance of 20–22%. Investors will examine the company’s outlook for technology spending, large-deal execution and demand across major client industries. The guidance and quarterly margin performance will remain important factors for evaluating its business outlook.
Kotak Mahindra Bank
Kotak Mahindra Bank reported a 29.5% year-on-year increase in standalone net profit to ₹4,212 crore, compared with ₹3,253.3 crore a year earlier. Net interest income increased 15.7% to ₹8,459 crore, while operating profit rose 21.1% to ₹6,382.2 crore.
The bank also reported an improvement in asset quality. Its gross non-performing asset ratio declined to 1.04% from 1.18% in the previous quarter, while the net NPA ratio fell to 0.24% from 0.27%. Investors will monitor deposit growth, lending activity, funding costs and the sustainability of profitability.
Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories reported a 36% year-on-year decline in consolidated net profit to ₹913.4 crore, compared with ₹1,426.8 crore in the corresponding quarter last year. Consolidated revenue declined 1.5% to ₹8,670.8 crore from ₹8,805.1 crore.
Also Read: Top Q2 Earnings: Infosys, Adani Power, Dr Reddy’s and More
The weaker earnings performance places attention on the company’s operating profitability and business performance across its pharmaceutical markets. Investors will examine management commentary on product sales, competition, research expenditure and new launches. The results will also be assessed for indications of how international operations are contributing to overall financial performance.
IndusInd Bank
IndusInd Bank reported a standalone net profit of ₹1,176.1 crore for the September quarter, compared with a loss of ₹444.8 crore a year earlier. Net interest income increased 3.6% to ₹4,569.5 crore, while operating profit rose 37% to ₹2,778 crore.
Provisions and contingencies declined 53.6% to ₹1,216.2 crore. Asset-quality indicators also improved sequentially, with the gross NPA ratio falling to 2.73% from 3.25% and the net NPA ratio declining to 0.83% from 0.95%. Investors will monitor loan growth, deposit mobilisation and the sustainability of the improvement in credit costs.
Bank of India
Bank of India reported a 25.4% year-on-year increase in standalone net profit to ₹3,202.4 crore, compared with ₹2,554.6 crore in the corresponding quarter last year. Net interest income rose 18.5% to ₹7,007.2 crore, while operating profit increased 33.2% to ₹5,089 crore.
Also Read: Indian Markets: 10 Fresh Developments to Watch on October 26
However, provisions and contingencies increased 80.7% to ₹797.4 crore. Asset quality improved sequentially, with the gross NPA ratio declining to 1.60% from 1.81% and the net NPA ratio falling to 0.42% from 0.51%. Investors will examine credit costs, lending growth and operating profitability.
Coforge
Coforge reported a 56.5% year-on-year increase in consolidated net profit to ₹588.1 crore, compared with ₹375.8 crore a year earlier. Revenue increased 53.6% to ₹6,170.8 crore from ₹4,016.4 crore.
The substantial increase in revenue and profitability places attention on the company’s business expansion and execution capabilities. Investors will examine organic growth, the contribution from acquired operations, operating margins and new contract bookings. Management commentary on client demand and technology spending will provide additional context for assessing future performance.
Torrent Pharmaceuticals
Torrent Pharmaceuticals reported a 9.6% year-on-year decline in consolidated net profit to ₹534 crore, compared with ₹591 crore in the corresponding period last year. Revenue increased 50.8% to ₹4,979 crore from ₹3,302 crore.
Also Read: Indian Market Opening Today: GIFT Nifty Signals Cautious Start as Oil and Fed Risks Weigh
The difference between revenue growth and profit performance will be an important area of investor attention. Operating expenses, business mix and other financial factors will be examined to understand the company’s profitability. Investors will also monitor management commentary on domestic pharmaceutical demand, international operations and future product launches.
Netweb Technologies
Netweb Technologies reported a 334.8% year-on-year increase in quarterly net profit to ₹136.7 crore, compared with ₹31.4 crore a year earlier. Revenue increased 335.7% to ₹1,323.3 crore from ₹303.7 crore.
The sharp expansion in revenue and profit highlights significant growth in the company’s computing infrastructure business. Netweb operates in high-performance computing and artificial intelligence infrastructure, among other specialised technology segments. Investors will examine order execution, operating margins, customer demand and the sustainability of its recent growth.
Apollo Micro Systems
Apollo Micro Systems reported a 55.7% year-on-year increase in consolidated net profit to ₹48.4 crore, compared with ₹31.1 crore in the corresponding quarter last year. Revenue rose 72.3% to ₹388.1 crore from ₹225.3 crore.
Also Read: US Stock Market Week Ahead: Fed Decision, Big Tech Earnings and GDP (Oct 26-30, 2026)
The company operates in defence electronics and specialised electronic systems. Investors will examine project execution, operating margins, working-capital requirements and future business opportunities. The earnings growth indicates stronger reported financial performance, although the contribution from individual projects and future orders will require continued monitoring.
Paytm (One 97 Communications)
One 97 Communications, the parent company of Paytm, is scheduled to announce its financial results for the quarter ended September 30, 2026, on Monday, October 26. The company’s investor calendar also lists its Q2 FY27 earnings call for October 27.
Investors will focus on revenue growth, operating profitability, payment-services activity and financial-services distribution. Merchant engagement, transaction volumes, operating expenses and regulatory requirements remain relevant to the company’s business performance. The earnings announcement and subsequent management commentary will provide further information about its operating priorities.
What Investors Will Watch Today
Monday’s session brings a combination of strong earnings growth, improving asset-quality indicators at selected banks and weaker profitability in parts of the pharmaceutical sector. Infosys and Coforge reported higher revenue and profit, while Kotak Mahindra Bank, IndusInd Bank and Bank of India announced improved quarterly profitability.
Also Read: Top 10 Fresh Indian Market News Today: RailTel, Petronet LNG, IndiGo and More
Netweb Technologies and Apollo Micro Systems reported substantial earnings growth, while Dr. Reddy’s Laboratories and Torrent Pharmaceuticals posted lower profits. Paytm’s scheduled quarterly results will provide an additional company-specific development.
Investors will also monitor institutional activity, global equities and crude oil prices as the market begins a new trading week following four consecutive sessions of benchmark declines.
Disclaimer: This article is for educational and informational purposes only and should not be considered investment advice or a recommendation to buy or sell any stock. Onetrader is not a SEBI-registered investment adviser. Investors should conduct their own research and consult a qualified financial adviser before making investment decisions.
Also Read: Top Earnings Today: IDFC FIRST Bank, Kotak, AU SFB and SBFC Finance
Keep learning with OneTrader
Explore structured lessons and practical guides to build your market knowledge.
